News & Publications

The US District Court for the Central District of California on July 18, 2019, held that that Disney’s agreement with distributors to forbid downstream sales to Redbox does not violate copyright law.

The US Court of Appeals for the Federal Circuit on July 12, 2019, ruled that Dr. Reddy’s Laboratories Ltd. does not have to halt sales of its generic version of the opioid addiction treatment Suboxone Film. Indivior Inc. v. Dr. Reddy’s Laboratories, S.A., Fed. Cir., 17-2587, 7/12/19.

On July 17, 2019, a joint letter from AIPLA and other stakeholders was sent to US Secretary of State Michael Pompeo and US Secretary of Commerce Wilbur Ross supporting an appropriate elevation in rank for qualified USPTO Intellectual Property attachés.

The US Patent and Trademark Office will host its “Apollo 50: The role of intellectual property in space commerce” event on July 23, 2-4:30 pm EST at its headquarters in Alexandria, VA.

The US Patent and Trademark Office (USPTO) on July 15, 2019, published a second update to the AIA Trial Practice Guide (TPG) containing additional guidance about trial practice before the Patent Trial and Appeal Board (PTAB).

The United States Patent & Trademark Office published a new examination guide titled, "Examination of Specimens for Use in Commerce: Digitally Created or Altered and Mockup Specimens."

The US Court of Appeals for the Federal Circuit on July 10, 2019, held that General Electric Co.‘s position as a patent owner’s competitor was insufficient to establish standing to appeal a Patent Trial and Appeal Board decision.

The US Patent and Trademark Office on July 10, 2019, designated as precedential Focal Therapeutics, Inc. v. SenoRx, Inc., Case IPR2014-00116 (PTAB July 21, 2014) (Paper 19).

The IP Practice in China Committee delegation kicked of this year's trip with a dinner with Dennis Duncan, the USPTO IP Attache based in Beijing, who provided a briefing of current developments in China.

The US Court of Appeals for the Federal Circuit on July 5, 2019, held that the Patent Trial & Appeal Board must reexamine Global IP Holdings LLC’s bid to broaden the scope of its patent.